Curis reported $29.43M in Loan Capital for its fiscal quarter ending in June of 2024.





Loan Capital Change Date
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Amgen USD 51.61B 250M Sep/2026
AstraZeneca USD 28.8B 2.79B Sep/2026
Bayer EUR 37.7B 6.54B Sep/2026
Bristol-Myers Squibb USD 41.85B 244M Sep/2026
CSL USD 10.42B 273M Dec/2025
Curis USD 29.43M 10.69M Jun/2024
Eli Lilly USD 46.99B 872M Sep/2026
Gilead Sciences USD 23.82B 17M Sep/2026
GlaxoSmithKline GBP 21.7B 7.75B Sep/2026
Incyte USD 28.42M 994K Jun/2026
Merck USD 49.69B 1.39B Sep/2026
Novartis USD 38.38B 893M Sep/2026
Pfizer USD 60B 498M Sep/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 16.28B 1.63B Sep/2026
Takeda JPY 4.17T 245.32B Sep/2026
TG Therapeutics USD 745.63M 247K Sep/2026
Verastem USD 76.87M 4.46M Mar/2026